25-OH Vitamin D Interpretation by Decade of Life

Is there a different normal range for each decade?

No decade-specific target has been established. The IOM 2011 report found that 16 ng/mL (40 nmol/L) covers the requirement of about half the population and 20 ng/mL (50 nmol/L) covers at least 97.5%. Levels above 30 ng/mL (75 nmol/L) were not consistently associated with more benefit, and levels above 50 ng/mL (125 nmol/L) should raise concern about adverse effects [2]. These are population requirement levels, not individual diagnostic cutoffs, and the report did not set separate levels for the 20s, 40s or 70s.

The Centers for Disease Control and Prevention (CDC) uses its own labels in its NHANES analysis: below 30 nmol/L (about 12 ng/mL) is at risk of deficiency, and 30 to 49 nmol/L (about 12 to 19.6 ng/mL) is at risk of inadequacy [3]. These labels do not change by decade.

The Endocrine Society 2024 guideline says there is no clear evidence defining an optimal 25(OH)D for disease prevention. It states the society no longer endorses its 2011 target of 30 ng/mL (75 nmol/L) or specific levels for sufficiency, insufficiency or deficiency, and it does not set a competing number [4]. The USPSTF notes that no single serum cut-point defines deficiency [6].

What changes with age: intake and who is targeted

The daily recommendation changes at age 71. The IOM RDA is 600 IU (15 mcg) for ages 1 to 70, including pregnancy and lactation, and 800 IU (20 mcg) for ages 71 and older; infants 0 to 12 months have an adequate intake of 400 IU (10 mcg) [1][2]. The adult upper limit is 4,000 IU (100 mcg) daily, which is a ceiling, not a target [2]. Children have lower ceilings: 2,500 IU for ages 1 to 3 and 3,000 IU for ages 4 to 8 [2].

The Endocrine Society 2024 suggestions are age-specific. It suggests empiric vitamin D for children and adolescents 1 to 18, adults 75 and older, pregnancy, and adults with high-risk prediabetes; it suggests against empiric supplementation above the DRI in healthy adults younger than 75 [4]. It also suggests against routine 25(OH)D testing in the populations it considered, including people with obesity or dark skin [4]. These are conditional recommendations for people without an established indication for treatment or testing [4].

Children and adolescents (1 to 18)

The IOM requirement level is 20 ng/mL (50 nmol/L) for ages 1 and older [1][2]. The age-specific part is the intake and the reason for supplementing: the Endocrine Society 2024 suggests empiric vitamin D for children and adolescents 1 to 18 to prevent nutritional rickets and possibly respiratory infections [4]. Nutritional rickets is a preventable vitamin D and calcium deficiency problem in infants, children and adolescents [7].

In NHANES 2011-2014, children aged 1 to 5 had the lowest prevalence at risk of deficiency, 0.5% [3]. A result of 18 ng/mL, for example, is above the CDC deficiency-risk line of about 12 ng/mL but below the IOM requirement level of 20 ng/mL [3][2].

The twenties and thirties (20 to 39)

This is the age band with the highest measured risk in the US survey. In NHANES 2011-2014, 7.6% of adults aged 20 to 39 were at risk of deficiency, compared with 2.9% of adults aged 60 and older; the prevalence at risk of inadequacy followed a similar pattern [3]. Overall, 5.0% of the population was at risk of deficiency and 18.3% at risk of inadequacy [3].

Fertility data are observational. In a study of 84 infertile women having IVF, higher 25(OH)D in follicular fluid was associated with clinical pregnancy; after adjustment for age, BMI, ethnicity and number of embryos transferred, each 1 ng/mL increase in follicular fluid 25(OH)D increased the likelihood of clinical pregnancy by 6% [8]. That finding does not establish a serum cutoff or a target for the decade.

For pregnancy, ACOG states there is insufficient evidence to recommend screening all pregnant women. For women thought to be at increased risk, maternal 25(OH)D can be considered; when deficiency is identified during pregnancy, most experts agree that 1,000 to 2,000 IU per day is safe, and higher treatment doses have not been studied in pregnancy [9].

The forties and fifties (40 to 59)

The IOM requirement level stays 20 ng/mL and the RDA stays 600 IU through age 70 [1][2]. The Endocrine Society 2024 guideline states it no longer endorses its 2011 target of 30 ng/mL [4].

For part of this age range, VITAL studied men 50 and older and women 55 and older. Vitamin D3 at 2,000 IU daily did not reduce invasive cancer (HR 0.96, 95% CI 0.88 to 1.06), major cardiovascular events (HR 0.97, 95% CI 0.85 to 1.12) or total fractures (HR 0.98, 95% CI 0.89 to 1.08) in participants who were not selected for low vitamin D, low bone mass or osteoporosis [11][12].

For fracture prevention in postmenopausal women, the USPSTF found adequate evidence that 400 IU or less of vitamin D daily with 1,000 mg or less of calcium has no benefit [13].

The sixties (60 to 69)

The same 20 ng/mL requirement level applies [1][2]. The RDA is still 600 IU until age 71 [1]. In NHANES 2011-2014, 2.9% of adults 60 and older were at risk of deficiency, lower than the 7.6% in adults 20 to 39 [3].

A healthy adult in this decade without an established indication falls into the group for which the Endocrine Society 2024 suggests against empiric vitamin D above the DRI [4]. In VITAL, 2,000 IU daily did not reduce total, nonvertebral or hip fractures in adults not selected for low vitamin D or osteoporosis [12].

The seventies and older (70+)

The RDA rises to 800 IU (20 mcg) at age 71 [1][2]. The adult upper limit remains 4,000 IU daily [2]. The Endocrine Society 2024 suggests empiric vitamin D for adults 75 and older, with possible lower mortality, and suggests daily dosing over intermittent high doses for adults over 50 who need vitamin D [4]. It still suggests against routine 25(OH)D testing in the populations it considered [4].

The IOM level of 20 ng/mL covers at least 97.5% of people age 1 and older, and values above 30 ng/mL were not consistently associated with more benefit [2].

Reference points used by different bodies

• Below 12 ng/mL (30 nmol/L): CDC at risk of deficiency [3].
• 12 to 19.6 ng/mL (30 to 49 nmol/L): CDC at risk of inadequacy, and below the IOM requirement level [3][2].
• 20 ng/mL (50 nmol/L) or above: meets the IOM requirement level for at least 97.5% of the population [1][2].
• Above 30 ng/mL (75 nmol/L): not consistently linked to more benefit by the IOM [2].
• Above 50 ng/mL (125 nmol/L): the IOM says this should raise concern about potential adverse effects [2].
• Above 150 ng/mL (375 nmol/L): the hallmark of toxicity from overdosing [5].

Risk also differs by population. In NHANES 2011-2014, 17.5% of non-Hispanic Black people were at risk of deficiency, compared with 2.1% of non-Hispanic white people [3]. That is a group figure, not a diagnosis for an individual result.

What toxicity looks like

Vitamin D toxicity is rare and is almost always from very large doses of pharmacologic products or manufacturing and labeling errors [5][15]. Symptoms are those of hypercalcemia: confusion, apathy, recurrent vomiting, abdominal pain, polyuria, polydipsia and dehydration [5]. In two documented US cases, supplements contained more than 1,000 times the labeled daily vitamin D3 dose; 25(OH)D took about a year to normalize, and both patients became normocalcemic and asymptomatic once 25(OH)D fell below 400 ng/mL, without long-term sequelae [15]. The prescription ergocalciferol label states that the range between therapeutic and toxic doses is narrow [16].